You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Test for Occult Micrometastases in Primary Breast Cancer
SBC: BCR DIAGNOSTICS, INC. Topic: N/AWe will develop and validate a new assay system to replace existing immunocytochemicalassays for detecting occult micrometastases in bone marrow of patients with primary breast cancer.This assay would offer simplicity, low cost, and a quantitative end point. The assay is based on aninnovative amplification mechanism, the bacterial chain reaction (BCR), which is potentially capable oflowering the d ...
SBIR Phase I 1994 Department of Health and Human Services -
IMMUNOISOLATED CELL TRANSPLANTS FOR TREATMENT OF PARKINSON'S DISEASE
SBC: Cellular Transplants Inc Topic: N/ASTRIATAL TRANSPLANTATION OF NEUROTRANSMITTER CELLS, IMMUNOISOLATED WITHIN A PERMSELECTIVE POLYMER MEMBRANE CAPSULE, REPRESENTS A NOVEL APPROACH TO THE TREATMENT OF PARKINSON'S DISEASE. THE TECHNIQUE HAS HAD PROMISING RESULTS IN SEVERAL RODENT MODELS, AND PRIMATE STUDIES ARE UNDERWAY. THE OVERALL OBJECTIVE OF THIS RESEARCH IS TO COMPLETE THE DEVELOPMENTS NECESSARY FOR WIDESPREAD MEDICAL ACCEPTANCE ...
SBIR Phase I 1990 Department of Health and Human Services -
AN IMPROVED BIOARTIFICIAL ENDOCRINE PANCREAS
SBC: Cellular Transplants Inc Topic: N/ATHE LONG-TERM OBJECTIVE OF THIS RESEARCH IS THE DEVELOPMENT AND INTRODUCTION TO MEDICAL PRACTICE OF AN EFFECTIVE BIOCOMPATIBLE IMPLANTABLE HYBRID ARTIFICIAL ENDOCRINE PANCREAS THAT IS CAPABLE OF SIGNIFICANT IMPROVEMENT IN THE THERAPY OF INSULIN-DEPENDENT DIABETES. THE SPECIFIC AIM OF THIS PROJECT IS TO EXTEND AND MODIFY A PROCESS FOR CELLULAR ENCAPSULATION TO THE ISLETS OF LANGERHANS, USING A CO-E ...
SBIR Phase I 1990 Department of Health and Human Services -
Xenograft Heart Valves--Biomechanics/Collagen Structure
SBC: CRYOLIFE, INC. Topic: N/AThough allograft human aortic valves are preferred for transplantation by virtue of their lowthrombogenicity and immunogenicity, superior hemodynamic performance, and extended durability, onlyabout 2,000 per year are implanted due to limited donated heart supply. An acellular porcine heart valvecould form the substrate of a heart valve graft after the removal of native cells and soluble proteins t ...
SBIR Phase I 1994 Department of Health and Human Services -
ENGINEERED HEART VALVE--FLOW AND FIBROBLAST FUNCTION
SBC: CRYOLIFE, INC. Topic: N/AN/A
SBIR Phase I 1996 Department of Health and Human Services -
CRYOPRESERVED ARTERIES AS ALLOGRAFT VASCULAR CONDUIT
SBC: CRYOLIFE, INC. Topic: N/AN/A
SBIR Phase I 1997 Department of Health and Human Services -
EVALUATION OF CRL1072 FOR TREATMENT OF MYCOBACTERIUM AV
SBC: CYTRX CORPORATION Topic: N/AN/A
SBIR Phase I 1996 Department of Health and Human Services -
REAL-TIME, DIGITAL SIGNAL PROCESSING FOR HEARING AIDS
SBC: Digital Communications Res Inc Topic: N/ASENSORINEURAL HEARING IMPAIRMENTS, IN GENERAL, AND RECRUITMENT OF LOUDNESS, IN PARTICULAR, HAVE NOT BEEN SUCCESSFULLY TREATED WITH CURRENTLY AVAILABLE HEARING AIDS. TO DATE, THESE AIDS MOSTLY AMPLIFY SOUNDS, OFTEN ON A FREQUENCY-DEPENDENT BASIS. ANALOG WIDEBAND AND MULTIBAND AIDS EMPLOYING AMPLITUDE COMPRESSION HAVE MET LIMITED SUCCESS. DIGITAL SIGNAL PROCESSING PROVIDES GREATER FLEXIBILITY AND LE ...
SBIR Phase I 1990 Department of Health and Human Services -
CLINICAL MANAGEMENT SOFTWARE FOR BEHAVIORAL HEALTHCARE
SBC: Earley Corporation Topic: N/AN/A
SBIR Phase I 1997 Department of Health and Human Services -
LUMINESCENCE DETECTION REAGENTS FOR PROTEINS
SBC: Ela Technologies Inc Topic: N/AELA TECHNOLOGIES, INC., HAS PRODUCED TWO BIOLUMINESCENT PROTEINS DESIGNATED RECAEQUORIN AND RECLUCIFERASE. THESE PROTEINS PRODUCE LIGHT WITH HIGH EFFICIENCY AND ARE DETECTABLE ON FILM IN THE PICOGRAM RANGE. RECAEQUORIN PRODUCES A FLASH OF LIGHT UPON THE ADDITION OF CALCIUM, AND RECLUCIFERASE PRODUCES A SUSTAINED SIGNAL IN THE PRESENCE OFITS SUBSTRATE, COELENTERATE LUCIFERIN. THIS RESEARCH WILL EVA ...
SBIR Phase I 1990 Department of Health and Human Services